Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants

American Journal of Pathology

Volumn 163, Issue 2, 2003, Pages 401-411

  Al Lamki, Rafia S ^a   Wang, Jun ^a   Thiru, Sathia ^b   Pritchard, Nicholas R ^a   Bradley, J Andrew ^c   Pober, Jordan S ^d   Bradley, John R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; SILENCER OF DEATH DOMAINS PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY GRAFT REJECTION; KIDNEY TUBULE EPITHELIUM; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 0042346056     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63670-X     Document Type: Article

References (20)

1. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan D, Xing L, Gentz R, Ni J, Dixit VM: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996, 274:990-992
2. Berglund H, Olerenshaw D, Sankar A, Federwisch M, McDonold NQ, Sriscoll PC: The three-dimensional solution structure and dynamic properties of the human FADD death domain. J Mol Biol 2000, 302: 171-188
3. Bradley JR, Thiru S, Pober JS: Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995, 146:27-32
4. Al-Lamki RS, Wang J, Skepper J, Thiru S, Pober JS, Bradley JR: Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest 2001, 81:1503-1515
5. Jiang Y, Woronicz JD, Lui W, Goeddel DV: Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 1999, 283:543-546
6. Miki K, Eddy EM: Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain. Mol Cell Biol 2002, 22:2536-2543
7. Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinhan CJ, Brown R, Farrow SN: A death-domain-containing receptor that mediates apoptosis. Nature 1996, 384:372-375
8. Kaptein A, Jansen M, Dilaver G, Kitson J, Dash L, Wang E, Owen MJ, Bodmer JL, Tscopp J, Farrow SN: Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3). FEBS Lett 2000, 485:135-141
9. Bodmer JL, Burns K, Schneider P, Hofmann K, Steriner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumour necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 1997, 6:79-88
10. Warzocha K, Ribeiro P, Charlot C, Renard N, Coiffier B, Salles G: A new death receptor 3 isoform: expression in human lymphoid cell lines and non-Hodgkin's lymphomas. Biochem Biophys Res Commun 1998, 242:376-379
11. Eggert A, Grotzer MA, Zuzak TJ, Ikegaki N, Zhao H, Brodeur GM: Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system. Eur J Can 2002, 38:92-98
12. Harrison DC, Roberts J, Campbell CA, Crook B, Davis R, Deen K, Meakin J, Michalovich D, Price J, Stammers M, Maycox PR: TR3 death receptor expression in the normal and ischaemic brain. Neuroscience 2000, 96:147-160
13. Jordan JF, Kociok N, Grisanti S, Jacobi PC, Esser JM, Luther TT, Krieglstein GK, Esser P: Specific features of apoptosis in human lens epithelial cells induced by mitomycin C in vitro. Graefes Arch Clin Exp Opthalmol 2001, 239:613-618
14. Chicheporteche Y, Bourdon PR, Xu H, Hsu, Y-M, Scott H, Hessin C, Garcia I, Browning JL: TWEAK, a secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997, 272:32401-32410
15. Daniel PT, Wieder T, Sturm I, Schulze-Osthoff K: The kiss of death: promises and failures of death receptors and ligands in cancer therapy. Leukemia 2001, 15:1022-1032
16. Muzio M: Signalling by proteolysis: death receptors induce apoptosis. Int J Clin Lab 1998, 28:141-147
17. Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD: APO-3, a new member of the tumor necrosis factor receptor family contains a death domain and activates apoptosis and NF-κB. Curr Biol 1996, 12:1669-1676
18. Tan KB, Harrop J, Reddy M, Young P, Terret J, Emery J, Moore G, Truneh A: Characterization of a novel TNF-like ligand and recently described TNF ligand and receptor superfamily and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 1997, 204:35-46
19. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P: TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492
20. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation, Science 1998, 281:1305-1308